• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

AMAG Pharmaceuticals Inc

+ Add to Watchlist

AMAG:US

32.5200 USD 2.8000 9.42%

As of 14:59:24 ET on 09/30/2014.

Snapshot for AMAG Pharmaceuticals Inc (AMAG)

Open: 30.9500 Day's Range: 30.7800 - 33.5650 Volume: 2,628,118
Previous Close: 29.7200 52wk Range: 16.4900 - 33.5650 1-Yr Rtn: +51.44%

Stock Chart for AMAG

No chart data available.
  • AMAG:US 32.5200
  • 1D
  • 1M
  • 1Y
29.7200
Interactive AMAG Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for AMAG

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3563
Est. EPS (USD) (12/2014) -0.5980
Est. PEG Ratio -
Market Cap (M USD) 703.76
Shares Outstanding (M) 21.96
30 Day Average Volume 419,376
Price/Book (mrq) 3.6999
Price/Sale (ttm) 7.9687
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 10/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for AMAG

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for AMAG

AMAG Pharmaceuticals, Inc., a biopharmaceutical company, utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.

William K HeidenPresident/CEOFrank E ThomasExec VP/COO
Steve CaffeSenior Vice PresidentMelissa Bradford KlugSenior VP:Bus Dev & Strategy
More Company Profile & Key Executives for AMAG

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil